The weekly litigation news digest is live. Subscribe now

IP Verse

Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders - EP3310760

The patent EP3310760 was granted to Arena Pharmaceuticals on Oct 19, 2022. The application was originally filed on Jun 21, 2016 under application number EP16734529A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3310760

ARENA PHARMACEUTICALS
Application Number
EP16734529A
Filing Date
Jun 21, 2016
Status
Granted And Under Opposition
Aug 12, 2022
Publication Date
Oct 19, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZJun 14, 2023KRAUS & LEDERER PARTGMBBADMISSIBLE
SCORPIOJun 14, 2023SAGITTARIUSADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2010011316
DESCRIPTIONWO2011094008
INTERNATIONAL-SEARCH-REPORTWO2010011316
INTERNATIONAL-SEARCH-REPORTWO2011094008
OPPOSITIONWO2006060808
OPPOSITIONWO2010011316
OPPOSITIONWO2011094008

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents